from Pharmabiz.com by Laxmi Yadav Positive Bioscience, India’s leading genomics company offering personal genomics and cancer genomics products, plans to launch more than 200 personalised genetic testing facilities across the country over a span of three years. The objective is ...
Read More »NuGEN Introduces Target Enrichment Technology for Comprehensive Detection of Gene Fusion Events in Oncology Research and Clinical Testing
SAN CARLOS, Calif.–(BUSINESS WIRE)–NuGEN Technologies, Inc., a market leader in the development of solutions for Next Generation Sequencing (NGS) applications, has announced the release of a novel targeted enrichment method that, in a single assay, will detect all possible fusion ...
Read More »Next Generation Sequencing: Research to Clinic Conference
SELECTBIO is hosting its Next Generation Sequencing: Research to Clinic Conference to bring together delegates from around the world focusing on technology development, informatics/data analysis, and applications of next generation sequencing (NGS) in various research fields and the migration of ...
Read More »